Why? they already spent millions on market end of 2015 and start of 2016 which was expected as it was their product launch and now their product is out there, it all about word of mouth (which is the most effective marketing product and cost them nothing), if they have a good product people will buy........the marketing cost in Q1 and Q2 has been most concern for some investors.
- Forums
- ASX - By Stock
- NOR
- Ann: Balance Sheet and Budget Update for FY17-NOR.AX
Ann: Balance Sheet and Budget Update for FY17-NOR.AX, page-174
Featured News
Add NOR (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.24M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 46822 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 233145 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 46822 | 0.032 |
2 | 114106 | 0.031 |
2 | 35400 | 0.030 |
1 | 96000 | 0.028 |
1 | 180000 | 0.027 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 233145 | 1 |
0.038 | 26342 | 1 |
0.039 | 126001 | 1 |
0.040 | 123849 | 1 |
0.042 | 23833 | 1 |
Last trade - 16.12pm 15/11/2024 (20 minute delay) ? |
Featured News
NOR (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online